Insider Transactions in Q2 2025 at Catalyst Pharmaceuticals, Inc. (CPRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,600
-3.75%
|
$41,600
$26.42 P/Share
|
|
Jun 10
2025
|
Preethi Sundaram Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,324
-5.16%
|
$60,424
$26.41 P/Share
|
|
Jun 09
2025
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
171,748
-3.86%
|
$4,465,448
$26.11 P/Share
|
|
Jun 06
2025
|
Patrick J Mcenany Director |
SELL
Open market or private sale
|
Direct |
28,252
-0.63%
|
$706,300
$25.95 P/Share
|
|
May 30
2025
|
Richard J Daly President and CEO |
BUY
Open market or private sale
|
Direct |
70,000
+25.95%
|
$1,680,000
$24.86 P/Share
|
|
May 14
2025
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
44,000
-38.98%
|
$1,012,000
$23.63 P/Share
|
|
May 14
2025
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,000
+28.05%
|
$176,000
$4.64 P/Share
|
|
May 13
2025
|
Gary Ingenito Chief Med. & Reg. Officer |
SELL
Open market or private sale
|
Direct |
200,000
-74.38%
|
$4,600,000
$23.68 P/Share
|
|
May 13
2025
|
Gary Ingenito Chief Med. & Reg. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+42.66%
|
$600,000
$3.42 P/Share
|